CIK: 0001538653 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value ($000): $2,225,850 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 2,116,840 | $936,342 | 42.1% | $107.75 | +308.9% | COM | 225310101 |
| CMPR | CIMPRESS PLC | 3,906,492 | $491,319 | 22.1% | $129.96 | 0.0% | SHS EURO | G2143T103 |
| W | WAYFAIR INC | 3,516,606 | $317,796 | 14.3% | $46.74 | +99.6% | CL A | 94419L101 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $176,040 | 7.9% | $81.92 | +25.7% | COM | 981419104 |
| YELP | YELP INC | 4,956,026 | $172,618 | 7.8% | $30.71 | +10.5% | CL A | 985817105 |
| — | SYSTEMAX INC | 2,111,944 | $53,137 | 2.4% | $9.46 | — | COM | 871851101 |
| NUS | NU SKIN ENTERPRISES INC | 1,142,959 | $46,838 | 2.1% | $47.91 | -31.7% | CL A | 67018T105 |
| BFH | ALLIANCE DATA SYSTEMS CORP | 265,370 | $29,775 | 1.3% | $118.19 | -33.0% | COM | 018581108 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 1,851,851 | $1,648 | 0.1% | $1.03 | -19.2% | COM | 53566P109 |
| — | AGEX THEREPEUTICS INC | 185,185 | $337 | 0.0% | $2.99 | — | COM | 00848H108 |